Biomarkers and diagnostic tests for coagulopathies in the critically ill and injured

R.W. Dujardin

Biomarkers and diagnostic tests for coagulopathies in the critically ill and injured

R.W. Dujardin

Research output: PhD Thesis › Phd-Thesis - Research and graduation internal

Abstract

Coagulopathy is a severe complication of both critical illness and injury, contributing to morbidity and mortality. As such, there is a clear clinical need for improved hemostasis management. However, to date, methods of (early) detection of coagulopathy are limited.
Coagulopathy in the critically ill has many phenotypes, ranging from a hyper- to

Original language	English
Qualification	Doctor of Philosophy
Awarding Institution	University of Amsterdam
Supervisors/Advisors	Juffermans, Nicole, Supervisor Muller, Marcella, Co-supervisor
Award date	4 Jul 2023
Print ISBNs	9789464831955
Publication status	Published - 2023

Access to Document

https://hdl.handle.net/11245.1/67e154b6-db35-4793-9ad2-8b0819534067

Cite this

@phdthesis{9d64bf2d7ae1437f8bba0c51816238a1,

title = "Biomarkers and diagnostic tests for coagulopathies in the critically ill and injured",

abstract = "Coagulopathy is a severe complication of both critical illness and injury, contributing to morbidity and mortality. As such, there is a clear clinical need for improved hemostasis management. However, to date, methods of (early) detection of coagulopathy are limited. Coagulopathy in the critically ill has many phenotypes, ranging from a hyper- to",

author = "R.W. Dujardin",

year = "2023",

language = "English",

isbn = "9789464831955",

type = "Phd-Thesis - Research and graduation internal",

school = "University of Amsterdam",

}

TY - THES

T1 - Biomarkers and diagnostic tests for coagulopathies in the critically ill and injured

AU - Dujardin, R.W.

PY - 2023

Y1 - 2023

N2 - Coagulopathy is a severe complication of both critical illness and injury, contributing to morbidity and mortality. As such, there is a clear clinical need for improved hemostasis management. However, to date, methods of (early) detection of coagulopathy are limited. Coagulopathy in the critically ill has many phenotypes, ranging from a hyper- to

AB - Coagulopathy is a severe complication of both critical illness and injury, contributing to morbidity and mortality. As such, there is a clear clinical need for improved hemostasis management. However, to date, methods of (early) detection of coagulopathy are limited. Coagulopathy in the critically ill has many phenotypes, ranging from a hyper- to

M3 - Phd-Thesis - Research and graduation internal

SN - 9789464831955

ER -

Biomarkers and diagnostic tests for coagulopathies in the critically ill and injured

Abstract

Access to Document

Fingerprint

Cite this